References
- Abdel-Alim, A. M., Abdel-Kader, M. A., and El-Kossi, A. A., Synthesis and anti-inflammatory activity of certain new N, N'-Oxamides. Pharmazie, 35(H. 7), 394-398 (1980)
- Abu Shamate M., The role of the gastrointestinal microflora in the metabolism of drugs. Int. J. Pharm., 97, 1-13 (1993) https://doi.org/10.1016/0378-5173(93)90121-U
- Atlas, R. M., 'Handbook of Microbiological Media', 2nd ed., Lawrence C. Parks editor, 1996, CRC press, New York, pp.194, 99, 363
- Conant J. B., Lutz R. F., and Corson B. B., 'Organic Synthesis', 2d edn., Ed. By Blatt, A. H. and Gilman, H.;Collective Volume I (1941), John Wiley and Sons, Inc., New York, pp. 49-51
- Bodor, N. and Abdel Alim, A. M., Improved delivery through biological membranes. XIX: novel redox carriers for brainspecific chemical delivery systems. J. Pharm. Sci., 74(3), 241-245 (1985) https://doi.org/10.1002/jps.2600740304
- Bodor, N. and Farag, H. H., Improved delivery through biological membranes. XIV: brain-specific, sustained delivery of testosterone using a redox chemical delivery system. J. Pharm. Sci., 73(3), 385-389 (1984) https://doi.org/10.1002/jps.2600730324
- Borne, R. F., 'Nonsteroidal Anti-inflammatory Drugs', In 'Foye's Principles of Medicinal Chemistry', 5th ed., (T. L. Lemke, and D. A. Williams; eds) 2002, Alea and Febiger, Philadelphia, pp. 751-793
- Brown, J. P., McGarraugh, G. V., Parkinson, T. M., Wingard R. E., and Onderdonk, B., A polymeric drug for treatment of inflammatory bowel disease. J. Med. Chem., 26, 1300-1307 (1983) https://doi.org/10.1021/jm00363a015
- Chan, R. P., Pope, D. J., Gilbert, A. P., and Sacra, P. J., Baron, J. H., and Lennard-Jones J. E., Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide. Dig. Dis. Sci., 28(7), 609-615 (1983) https://doi.org/10.1007/BF01299921
- Coates, L. V., Drain, D. L., Kerridge, K. A., Macrae, F. J., and Tattersal, K., Preparation and antifungal activity of some salicylic acid derivatives. J. Pharm. Pharmacol., 9, 855-862 (1957); through Chem. Abstr. 52, 8087h (1958) https://doi.org/10.1111/j.2042-7158.1957.tb12347.x
- Davaran, S., Hanee, J., and Khosravi, A., Release of 5- aminosalicylic acid from acrylic type polymeric prodrugs designed for colon-specific drug delivery. J. Controlled Release, 58(3), 279-287 (1999); through Chem. Abstr., 131, 63362p (1999) https://doi.org/10.1016/S0168-3659(98)00167-9
- Duffy, J. C., Dearden, J. C., and Rostron, C., Design, synthesis and biological testing of a novel series of anti-inflammatory drugs. J. Pharm. Pharmacol., 53, 1505-514 (2001) https://doi.org/10.1211/0022357011778043
- Eddy, N. B. and Leimback, D., Synthetic analgesics II. Dithienylbutenyl and dithienylbutylamines. J. Pharmacol. Exp. Ther., 107, 385-393 (1953)
- Furniss, B. S., Hannaford, A. J., Smith, P. W. G., and Tatchell, A. R. (eds.), 'Vogel's Textbook of Practical Organic Chemistry' 5th edn., (1989), El BS with Longman, U.K., p. 952
- Hans, K. and Josef, K., Novel salicylic acid salt. DE 3340028 (1985-05-15)
- Hoult, J. R. S. and Dage, H., 5-Aminosalicylic acid, a co-factor for colonic prostacyclin synthesis? The Lancet, 2, 255 (1981) https://doi.org/10.1016/S0140-6736(81)90502-X
- Jensen, K. A. and Linholt, S. C., Some substituted amides of salicylic acid. Acta Chemica Scand., 3, 205-206 (1949) https://doi.org/10.3891/acta.chem.scand.03-0205
- Jones, H., Fordice, M. W., Greenwald, R. B., Hannah, J., Jacobs A., Ruyle, W. V., Walford, G. L., and Shen, T. Y., Synthesis and analgesic-antiinflammatory activity of some 4- and 5-substituted heteroarylsalicylic acids. J. Med. Chem., 21, 1100-1104 (1978) https://doi.org/10.1021/jm00209a002
- Jorgensen, A. P., Hvidovre and Torkil M., Benzoic acid derivatives and use thereof. US Pat. Appl. No., U.S. 4, 933, 330 (1990)
- Jorgensen, A. P. and Monne T., Aminosalicylic acid derivatives for the treatment of psoriasis, Eur. Pat. Appl. No., EP 291,159 (1988); through Chem. Abstr., 111, 102720n (1989)
- Jung, Y. J., Lee, J. S., and Kim, Y. M., Synthesis and in vitro/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid. J. Pharm. Sci., 89(5), 594-602 (2000) https://doi.org/10.1002/(SICI)1520-6017(200005)89:5<594::AID-JPS5>3.0.CO;2-8
- Margaretha, O. and Franciscus, H. R., Use of 5-aminosalicylic acid in the treatment of dermatological disordes. Eur. Pat. Appl. No., EP 0352826 (1990)
- Moller, N. L., Diet Zel, K. E., Schneider, H. T., and Brune, K., Novel 5-aminosalicylic acid NSAID conjugates: synthesis; pharmacological and toxicological properties. Eur. J. Med. Chem., 24, 463-469 (1989) https://doi.org/10.1016/0223-5234(89)90048-2
- Orlikovs, G., Medicine for the treatment of rheumatoid arthritis and similar diseases. Latv. Pat. Appl. No., LV 12, 370, 20, 2000; through Chem. Abstr., 134, 173026b (2001)
- Phelan, M. J. and Bodor, N., Improved delivery through biological membranes. XXXVII. synthesis and stability of novel redox derivatives of naproxen and indomethacin. Pharm. Res., 6(8), 667-676 (1989) https://doi.org/10.1023/A:1015930220855
- Peppercorn, M. A. and Goldman, P., The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. J. Phamacol. Exp. Ther., 181, 555-562 (1972)
- Rokos, H., Konczak, H., and Forth, W., 5-Aminosalicylic acid-Osulfates of physiologically acceptable bases, process for the preparation thereof and drugs containing same. US Pat. Appl. No., US 4, 837, 229 (1989)
- Shen, T. Y., Walford, G. L., Witzel, B. E., and Jones, H., Treatment of inflammation. US Pat. Appl. No., US 3, 632, 760 (1972)
- Singh, I. P., Gurtu, S., Kumar, A., Sinha, J. N., Bhargava, P., and Shanker, K., Anti-inflammatory activities of compounds derived from salicylic and benzoic acids. Arch. Pharm. (weinheim, Ger.), 317, 609-614 (1984) https://doi.org/10.1002/ardp.19843170707
-
Sztaricskai, F., Takacs, I. E., Pusztai, F., Szabo, G., and Csipo I., Antiulcer effect of the N- and O-
$\beta$ -D-glucopyranosides of 5-aminosalicylic acid. Arch. Pharm. Pharm. Med. Chem., 332, 321-326 (1999) https://doi.org/10.1002/(SICI)1521-4184(19999)332:9<321::AID-ARDP321>3.0.CO;2-A - Thomson, G. T. D., Thomson, B. R. J., Thomson, K. S., Ducharne, J. S., and Ducharne J. S., Clinical efficacy of mesalamine in the treatment of the spondyloarthropathies, J. Rheumatol., 27(3) 714 (2000); through Chem. Abstr., 132, 231684m (2000)
- Truelove, J., Bawarshi-Nassar, R., Chen, N. R., and Hassain, A., Solubility enhancement of some developmental anticancer nucloside analogs by complexation with nicotinamide. Int. J. Pharm., 19, 17-25 (1984) https://doi.org/10.1016/0378-5173(84)90128-5
- Way, E. L., Takemori, A. E., Smith, G. E., Anderson, H. H., and Brodie, D. C., The toxicity and analgetic activity of some congeners of salicylamide. J. Pharm. Exp. Ther., 108, 450-460 (1953)
- Willoughby, C. P., Aronson, J. R., Agback, H., Bodin, N. O., and Truelove, S. C., Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis. Gut, 23, 1081-1087 (1982) https://doi.org/10.1136/gut.23.12.1081
- Winter, C. A., Risley, E. A., and Nuss, G. W., Carrageenininduced oedema in the hind paw of rat as an assay for antiinflammatory activity. Proc. Soc. Exp. Biol. Ther., 111, 544-547 (1962) https://doi.org/10.3181/00379727-111-27849